{
  "docId": "019de073-1466-7584-8ab0-d467e4eba908",
  "docSlug": "8094e1caeccf03c1e07a7f57c9f4c117",
  "documentTitle": "AbCellera | Investor Presentation Deck | 37 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 37,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "traction",
  "function": "show_traction",
  "density": "balanced",
  "nDataPoints": 10,
  "notes": "The slide uses a nested donut chart to show both therapeutic area breakdown and health sector breakdown.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-1466-7584-8ab0-d467e4eba908/11",
  "deckHref": "/decks/019de073-1466-7584-8ab0-d467e4eba908",
  "deckJsonHref": "/decks/019de073-1466-7584-8ab0-d467e4eba908.json",
  "deckAnchorHref": "/decks/019de073-1466-7584-8ab0-d467e4eba908#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.5,
        "x": 0.45,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Therapeutic area breakdown (58% oncology, 17% neurology, etc.) and health sector breakdown (50% human health known, 39% human health TBD, 11% animal health)",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8800e7d9-cec5-48c5-86ab-776f9c6f82b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.09,
        "y": 0.68
      },
      "kind": "paragraph",
      "text": "Portfolio of 131 programs with downstream participation is diversified across the following therapeutic areas:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aad1f78c-083f-470d-acac-162e2f8c49ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.42,
        "x": 0.09,
        "y": 0.16
      },
      "kind": "title",
      "text": "LARGE DIVERSIFIED PORTFOLIO IN NEXT-GEN ANTIBODY THERAPIES.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5138c610-949c-435b-aecc-875da54be3bc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "4566b3a2-f260-4882-b1f7-a5f8112d8ef5",
      "evidence": "Therapeutic area breakdown (58% oncology, 17% neurology, etc.) and health sector breakdown (50% human health known, 39% human health TBD, 11% animal health)",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 14,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "2cca4bef-c109-4498-bf0e-3888be583570",
      "evidence": "The vision and solution sections address the why, what, and how of AbCellera's platform.",
      "position": 1,
      "objective": "Why does AbCellera's platform matter?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}